Citi Pharma approves IPO of subsidiary to raise up to Rs2 billion
Karachi, March 3, 2026 – The Board of Directors of Citi Pharma Limited has approved the initiation of an Initial Public Offering (IPO) of its wholly owned subsidiary, Citi Veterinary Pharma Limited, aiming to raise up to Rs2 billion.
Continue Reading